BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

WaferGen Biosystems 

Global Headquarters
46531 Fremont Boulevard
Fremont  California  94538  U.S.A.
Phone: 510-651-4450 Fax: 510-651-4599


SEARCH JOBS





Segment
Research





 Company News
Advanced Molecular Diagnostics Company, Admera Health, Implements WaferGen Biosystems's Next-Generation Sequencing Sample Prep Platform For Clinical Testing 12/18/2014 9:14:25 AM
WaferGen Biosystems Announces Third Quarter 2014 Results 11/7/2014 8:35:47 AM
WaferGen Biosystems Announces Third Quarter 2014 Conference Call 10/31/2014 7:35:23 AM
WaferGen Biosystems Announces The Launch Of Exome Capture Solutions On Its Next Generation Sequencing (NGS) Sample Preparation Platform Apollo 324™ 10/20/2014 9:22:44 AM
Versatility Of WaferGen Biosystems Next-Gen Sequencing (NGS) Sample Prep Solutions To Be Showcased At The American Society of Human Genetics 2014 Meeting 10/17/2014 8:08:24 AM
WaferGen Biosystems To Present At Upcoming Investment Conferences 9/5/2014 12:53:09 PM
WaferGen Biosystems Announces Successful Completion Of Public Offering Raising $20 Million 8/28/2014 11:39:40 AM
WaferGen Biosystems Announces Pricing Of $20 Million Underwritten Offering And Uplisting To NASDAQ 8/22/2014 7:24:16 AM
WaferGen Biosystems Announces Appointment Of Chief Operating Officer And Chief Financial Officer 8/18/2014 8:31:58 AM
WaferGen Biosystems Announces Second Quarter 2014 Conference Call 8/5/2014 7:11:51 AM
12345678910...